Product Information
METRONIDAZOLE 0.75% LOTION is a generic product labeled by Mayne Pharma, priced at $1.8173 per ML under NDC 68308071259. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Nov 24, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/g
Manufacturer
Mayne PharmaNDC
68308071259
Classification
Generic
Dosage Form
LOTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020901FDA Approved
11/24/1998
TE Code
AB
On Market Since
2/10/2025
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 0.75% LOTION has been published 78 times since Apr 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8173 per ML |
|---|---|
| All-time high | $1.9877 (Feb 11, 2026) |
| All-time low | $1.7923 (Aug 19, 2026) |
| 52-week high | $1.9877 |
| 52-week low | $1.7923 |
| Median price | $1.8917 |
| Average price | $1.8825 |
| Largest weekly change | -5.3% (Oct 22, 2025) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metronidazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 0.75% LOTION?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 0.75% LOTION, manufactured by Mayne Pharma, is $1.8173 per ML (NDC 68308071259), effective Sep 30, 2026.
How has the price of METRONIDAZOLE 0.75% LOTION changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 0.75% LOTION has held within roughly two percent of its current level. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 0.75% LOTION?
Since Apr 9, 2025, the NADAC for METRONIDAZOLE 0.75% LOTION has ranged from a low of $1.7923 (Aug 19, 2026) to a high of $1.9877 (Feb 11, 2026), with a median of $1.8917 per ML.
Are there cheaper alternatives to METRONIDAZOLE 0.75% LOTION?
No other NADAC-published product currently shares the active ingredient and strength of METRONIDAZOLE 0.75% LOTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METRONIDAZOLE 0.75% LOTION?
METRONIDAZOLE 0.75% LOTION (NDC 68308071259) is labeled by Mayne Pharma, and CMS classifies it as a generic product.